| Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer SA Sabra, AO Elzoghby, SA Sheweita, M Haroun, MW Helmy, ... European Journal of Pharmaceutics and Biopharmaceutics 128, 156-169, 2018 | 154 | 2018 |
| Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics AO Elzoghby, MW Helmy, WM Samy, NA Elgindy International journal of nanomedicine, 1721-1732, 2013 | 123 | 2013 |
| Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease … AS Hanafy, RM Farid, MW Helmy, SS ElGamal Drug delivery 23 (8), 3111-3122, 2016 | 105 | 2016 |
| Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy OM Ali, AA Bekhit, SN Khattab, MW Helmy, YS Abdel-Ghany, M Teleb, ... Colloids and Surfaces B: Biointerfaces 188, 110824, 2020 | 104 | 2020 |
| Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization, and in vivo pharmacokinetics AO Elzoghby, MW Helmy, WM Samy, NA Elgindy European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 487-496, 2013 | 104 | 2013 |
| Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma DM Kabary, MW Helmy, KA Elkhodairy, JY Fang, AO Elzoghby Colloids and Surfaces B: Biointerfaces 169, 183-194, 2018 | 94 | 2018 |
| Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy AO Elzoghby, SA El-Lakany, MW Helmy, MM Abu-Serie, NA Elgindy Nanomedicine 12 (24), 2785-2805, 2017 | 91 | 2017 |
| Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma MA Abdelmoneem, M Mahmoud, A Zaky, MW Helmy, M Sallam, JY Fang, ... Journal of Controlled Release 287, 78-93, 2018 | 85 | 2018 |
| Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX-2 inhibitor/herbal therapy of breast cancer AS AbdElhamid, DG Zayed, MW Helmy, SM Ebrahim, M Bahey-El-Din, ... Nanomedicine 13 (20), 2637-2656, 2018 | 82 | 2018 |
| Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer SW El-Far, MW Helmy, SN Khattab, AA Bekhit, AA Hussein, AO Elzoghby Nanomedicine 13 (5), 481-499, 2018 | 80 | 2018 |
| Inhalable lactoferrin–chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma MM Abd Elwakil, MT Mabrouk, MW Helmy, EZA Abdelfattah, SK Khiste, ... Nanomedicine 13 (16), 2015-2035, 2018 | 79 | 2018 |
| Liquid crystalline assembly for potential combinatorial chemo–herbal drug delivery to lung cancer cells HM Abdelaziz, AO Elzoghby, MW Helmy, MW Samaha, JY Fang, ... International journal of nanomedicine, 499-517, 2019 | 77 | 2019 |
| Multi-reservoir phospholipid shell encapsulating protamine nanocapsules for co-delivery of letrozole and celecoxib in breast cancer therapy AO Elzoghby, SK Mostafa, MW Helmy, MA ElDemellawy, SA Sheweita Pharmaceutical research 34, 1956-1969, 2017 | 72 | 2017 |
| Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy MM Elgohary, MW Helmy, EZA Abdelfattah, DM Ragab, SM Mortada, ... Journal of Controlled Release 285, 230-243, 2018 | 68 | 2018 |
| Dual-targeted lactoferrin shell-oily core nanocapsules for synergistic targeted/herbal therapy of hepatocellular carcinoma MA Abdelmoneem, MA Elnaggar, RS Hammady, SM Kamel, MW Helmy, ... ACS applied materials & interfaces 11 (30), 26731-26744, 2019 | 67 | 2019 |
| Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats AO Elzoghby, NI Saad, MW Helmy, WM Samy, NA Elgindy European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 444-451, 2013 | 66 | 2013 |
| Expanding the anticancer potential of 1, 2, 3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases PA Elzahhar, SM Abd El Wahab, M Elagawany, H Daabees, ASF Belal, ... European Journal of Medicinal Chemistry 200, 112439, 2020 | 60 | 2020 |
| Additive renoprotection by pioglitazone and fenofibrate against inflammatory, oxidative and apoptotic manifestations of cisplatin nephrotoxicity: modulation by PPARs MM Helmy, MW Helmy, MM El-Mas PLoS One 10 (11), e0142303, 2015 | 58 | 2015 |
| Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone RM Ali, MY Al-Shorbagy, MW Helmy, HS El-Abhar European Journal of Pharmacology 831, 68-76, 2018 | 57 | 2018 |
| Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model AO Elzoghby, MW Helmy, WM Samy, NA Elgindy Pharmaceutical research 30, 2654-2663, 2013 | 57 | 2013 |
